these folks get a minus D In performance and communication. Incredibly disheartening.
With todays news :First Patient Receives Gamida Cell's Omisirge™ (omidubicel-onlv) as well as todays news: Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting perhaps signaling a reversal in our complains as expressed above! The road ahead certainly looks more promising!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.